BioBoyScout (@BioBoyScout)

1/12 Quick thread on $ARWR's TIDES presentation yesterday on ARO-MAPT, their Alzheimer's drug. Most of the deck has been public since last September. But two new data points closed the last open question on the preclinical case. Here's what they mean:...